Bleeding while taking medroxyprogesterone is frustrating, but it’s not uncommon. The medication is prescribed to regulate periods, treat heavy bleeding, or protect the uterine lining, yet some people find they’re still spotting or bleeding through treatment. The reasons range from a normal adjustment period to underlying conditions that the medication alone can’t address.
Breakthrough Bleeding Is a Known Side Effect
The most common reason for bleeding on medroxyprogesterone is simply that your body is adjusting to the hormone. Progestins change the way your uterine lining builds up and sheds, and during the first few cycles of use, irregular spotting or light bleeding is a recognized side effect. This type of bleeding, called breakthrough bleeding, typically happens because the lining hasn’t fully stabilized under the new hormonal influence.
For many people, breakthrough bleeding improves within two to three cycles as the body adapts. If you’ve just started the medication or recently changed your dose, this adjustment period is the most likely explanation. The bleeding is usually lighter than a normal period, though it can be unpredictable in timing.
The Dose or Timing May Not Be Right
Medroxyprogesterone works differently depending on how it’s dosed and when it’s taken in your cycle. If the dose is too low for your particular situation, it may not be strong enough to fully suppress the uterine lining or control bleeding. Similarly, if you’re taking it cyclically (only certain days of the month) rather than continuously, some bleeding between courses is expected and part of how the regimen works.
Missing doses or taking them at inconsistent times can also trigger bleeding. Progestins need relatively stable levels to keep the uterine lining in check, and even small gaps can cause the lining to partially shed. If you’ve been inconsistent with timing, that alone could explain the bleeding.
Structural Problems the Medication Can’t Fix
Medroxyprogesterone treats hormonally driven bleeding, but it can’t resolve structural problems inside the uterus. Clinical guidelines are clear that structural and systemic causes should be ruled out before relying on progestin therapy alone. Several common conditions can cause persistent bleeding regardless of what hormonal medication you’re taking:
- Uterine fibroids: noncancerous growths in the uterine wall that can cause heavy or prolonged bleeding, especially when they bulge into the uterine cavity.
- Endometrial polyps: small tissue growths on the uterine lining that create irregular bleeding patterns and often don’t respond well to hormonal treatment.
- Adenomyosis: a condition where tissue similar to the uterine lining grows into the muscular wall of the uterus, causing heavy periods and cramping that progestins may only partially control.
If you had any of these before starting medroxyprogesterone, the medication may reduce bleeding somewhat but is unlikely to stop it completely. These conditions often need targeted treatment, sometimes procedural, to fully resolve the bleeding.
Endometrial Concerns Worth Knowing About
In some cases, persistent bleeding on progestin therapy can signal that the uterine lining isn’t responding as expected. Endometrial hyperplasia, where the lining becomes abnormally thick, is one condition medroxyprogesterone is specifically used to treat. But if bleeding continues despite treatment, it may mean the hyperplasia hasn’t resolved or has progressed.
This is particularly relevant for people over 45 or those with risk factors like obesity, polycystic ovary syndrome, or a long history of irregular periods. The American College of Obstetricians and Gynecologists notes that vaginal bleeding can be a symptom of recurrence or progression of endometrial disease, and clinicians should remain watchful for these changes. Persistent bleeding after adequate progestin therapy is one of the signals that further evaluation is warranted.
What Testing Looks Like
If your bleeding hasn’t improved after two or three cycles, your provider will likely want to investigate further. The standard first step is a transvaginal ultrasound, which can measure the thickness of your uterine lining and identify fibroids or polyps. For a more detailed look at the uterine cavity, a saline-infused sonogram (where sterile fluid is used to expand the uterus during imaging) increases the sensitivity for detecting abnormalities like polyps or submucosal fibroids.
For people over 45, or anyone with risk factors for endometrial disease, an endometrial biopsy is a standard next step. This involves taking a small tissue sample from the lining to check for hyperplasia or abnormal cells. The procedure is done in a clinic setting and takes only a few minutes, though it can cause cramping similar to a strong period cramp. If a biopsy is inconclusive or can’t be completed, a more thorough tissue sampling under sedation may be recommended.
Signs That Bleeding Needs Urgent Attention
Some level of irregular bleeding on medroxyprogesterone can be normal, but certain patterns cross into territory that needs prompt evaluation. The CDC defines heavy menstrual bleeding as needing to change your pad or tampon after less than two hours, or passing clots the size of a quarter or larger. Soaking through one or more pads every hour for several hours in a row is a threshold that warrants contacting your provider right away.
Other signs to take seriously: bleeding that lasts longer than seven days per cycle, needing to wake up multiple times at night to change protection, or feeling dizzy, lightheaded, or unusually fatigued (which can signal that blood loss is affecting your iron levels or blood volume). These symptoms don’t necessarily mean something dangerous is happening, but they do mean the current treatment plan isn’t working well enough and needs to be reassessed.
Why It Matters to Follow Up
The temptation when bleeding persists is to assume the medication just isn’t working and either stop it or wait it out. Neither approach is ideal. Stopping abruptly can trigger a heavier withdrawal bleed, and waiting indefinitely means a potentially treatable cause goes unaddressed. If you’ve given the medication a fair trial of two to three cycles at the correct dose and you’re still bleeding, that information is diagnostically useful. It tells your provider that the cause of your bleeding is likely not purely hormonal, narrowing down what needs to be investigated next.
Keep a record of your bleeding pattern: how many days, how heavy, and whether you notice clots. This simple tracking gives your provider significantly more to work with than a general description of “still bleeding.” Many people find that their bleeding does have a fixable cause, whether that’s adjusting the medication, treating a structural issue, or addressing an underlying condition that was missed on the initial workup.